VALIDATION OF MALDI-MS-BASED INHIBITOR SCREENING TECHNOLOGIES FOR CANCER TARGETS


Year of Award:
2011
Award Type:
R33
Project Number:
CA151210
RFA Number:
RFA-CA-10-004
Technology Track:
Molecular & Cellular Analysis Technologies
PI/Project Leader:
GREIS, KENNETH DONALD
Other PI or Project Leader:
N/A
Institution:
UNIVERSITY OF CINCINNATI
Validation of transformative MALDI-MS-based inhibitor screening technologies for cancer targets. Mass spectrometry (MS) has a long history as a transformative technology. Two specific examples include quantitative MS to measure the fate of drug compounds